DICOM enhances CT, MR device interoperability
The DICOM standard is changing with the times to include a new family of CT and MR objects.
The DICOM standard is changing with the times to include a new family of CT and MR objects.
SCAR, the National Electrical Manufacturer's Association, and DICOM are working with vendors to provide tools and an infrastructure for developing, testing, validating, and demonstrating new objects designed to support the rapidly advancing capabilities of CT and MR technologies.
Those test tools and sample images, along with open source code not yet publicly accessible, were expected to become available after the 2005 SCAR meeting.
The original DICOM CT object contained 18 attributes, none of them mandatory for vendors, and four terms, two of which were enumerated-meaning all vendors must comply. The enhanced CT object has 41 attributes, 39 of them mandatory, and 86 terms, 18 of them enumerated.
The original object for MR defined 44 attributes, only two of them mandatory, and 38 terms, nine of which were enumerated. The enhanced DICOM MR object includes 103 attributes, 94 of them mandatory, and 228 terms, 47 enumerated.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
